Core Scientific Inc vs Exelixis Inc. Common Stock — how do they compare? Core Scientific Inc trades at $15.29 (market cap $4.94B), while Exelixis Inc. Common Stock trades at $60.41 (market cap $14.62B). The key difference: Exelixis Inc. Common Stock is far larger — about 3× Core Scientific Inc's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Exelixis Inc. Common Stock for 1 Days on average.
| CORZ | EXEL | |
|---|---|---|
Market Cap | $4.94B | $14.62B |
Volume | 15,630,800 | 2,684,957 |
Sector | Technology | Health |
52-Week High | $29.16 | $59.13 |
52-Week Low | $13.57 | $34.54 |
Typical Hold Time | 20 Days | 1 Days |
Enterprise Value | $7.46B | $13.95B |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.30, down 4.02% today amid bearish technical signals and negative earnings momentum. The stock faces fundamental challenges with a net income margin of -324.9% and three consecutive quarterly earnings misses. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.75 consensus price target, while recent executive appointments and AI infrastructure developments provide potential catalysts.
Despite current financial struggles, CORZ shows potential through its pivot to AI data center services and strong institutional support. Key risks include persistent negative profitability, high capital expenditures, and cryptocurrency market volatility. The significant gap between current price and analyst targets suggests upside potential if the company executes its AI infrastructure strategy successfully.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →